A patient is a candidate for fertility drug therapy with human ...

[SAVANNAHHOOPER23]

A patient is a candidate for fertility drug therapy with human menopausal gonadotropin (hMG). By which route should the health care provider administer this drug?
 
  a. Intravaginal
  b. Intramuscular
  c. Subcutaneous
  d. Oral

Question 2

A female patient is taking bromocriptine (Parlodel) for hyperprolactinemia and infertility. She is anxious to have her infertility resolved and asks the health care provider how soon it will be be-fore she can see the therapeutic effects of the drug.
 
  The most appropriate response of the health care provider is that the most therapeutic effects of this drug can be seen after:
  a. 4 days
  b. 1 week
  c. 4 weeks
  d. 8 weeks

[blfontai]

Answer to Question 1

ANS: B
Human chorionic gonadotropin is destroyed in the gastrointestinal (GI) tract and therefore is ad-ministered parenterally.

Answer to Question 2

ANS: C
The most therapeutic effects in hyperprolactinemic patients are seen after 4 weeks of therapy.

[SAVANNAHHOOPER23]

Thanks

[blfontai]

Welcome